Skip to content

A clinical trial to study the effect of two drugs, rocuronium and cisatracurium in adults subjected to general anaesthesia.

A Comparative Study Of Intubating Doses Of Rocuronium And Cisatracurium In Adults Undergoing Elective Surgeries Under General Anaesthesia-A Double Blind Randomized Controlled Trial.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/05/014201
Enrollment
90
Registered
2018-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- All adults undergoing elective surgeries under general anaesthesia

Interventions

Intervention1: Endotracheal intubation with rocuronium: To assess and compare the feasibility of intubation using rocuronium and cisatracurium. Control Intervention1: Endotracheal intubation with cisa

Sponsors

Dr Paramanand Reddy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients posted for elective surgeries under general anaesthesia 2) ASA 1 and 2 3) Mallampatti grade 1 and 2 4) Surgery with duration more than 30 minute

Exclusion criteria

Exclusion criteria: 1) Restricted arm positions or likely changes in arm position during surgery 2) Patients who require rapid sequence intubation 3) Patients undergoing laparoscopic surgeries 4) Patients on aminoglycoside therapy or those who may need it intraoperatively

Design outcomes

Primary

MeasureTime frame
a)Hemodynamic variables(Heart rate; systolic, diastolic and mean arterial pressure) will be recorded at successive intervals like T0, T1, T2, T3, T4, T5, T6, T7, T8 and Tn. b) Intubating conditions assessed and graded based on ease of passage of tube with or without coughing/bucking and vocal cord position.Timepoint: T0-Before induction. T1-After induction. T2-After injection of neuromuscular blocker. T3-Just after intubation. T4, T5, T6, T7, T8-At a successive interval of 2min each after T3. Tn-At a successive interval of 10min each after T8.

Secondary

MeasureTime frame
a) onset time of neuromuscular blockade b) clinical duration of neuromuscular blockade c) recovery index d) any adverse reaction to the drugTimepoint: a) Time from injection of neuromuscular blocker to 95% supression of twitch height b) Time from injection of neuromuscular blocker to 25% recovery of twitch height c)Time from 25% to 75% recovery of twitch height

Countries

India

Contacts

Public ContactDr Paramanand Reddy

Father Muller Medical College

harshaomega@gmail.com9980124362

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026